Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015709
Filing Date
2024-11-14
Accepted
2024-11-14 16:07:34
Documents
91
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ganx-20240930x10q.htm   iXBRL 10-Q 2068113
2 EX-10.2 ganx-20240930xex10d2.htm EX-10.2 77711
3 EX-31.1 ganx-20240930xex31d1.htm EX-31.1 11315
4 EX-31.2 ganx-20240930xex31d2.htm EX-31.2 10503
5 EX-32.1 ganx-20240930xex32d1.htm EX-32.1 7871
  Complete submission text file 0001558370-24-015709.txt   8556570

Data Files

Seq Description Document Type Size
6 EX-101.SCH ganx-20240930.xsd EX-101.SCH 57908
7 EX-101.CAL ganx-20240930_cal.xml EX-101.CAL 56979
8 EX-101.DEF ganx-20240930_def.xml EX-101.DEF 222545
9 EX-101.LAB ganx-20240930_lab.xml EX-101.LAB 514064
10 EX-101.PRE ganx-20240930_pre.xml EX-101.PRE 400869
94 EXTRACTED XBRL INSTANCE DOCUMENT ganx-20240930x10q_htm.xml XML 1354711
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40237 | Film No.: 241462058
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)